Literature DB >> 1115789

Effect of colchicine on collagen, albumin and transferrin synthesis by cirrhotic rat liver slices.

M Rojkind, D Kershenobich.   

Abstract

Collagen synthesis was found to be increased in liver slices of rats made cirrhotic by chronic administration of CCl4. The liver function was impaired, as determined by an increased retention of conjugated bilirubin and low serum albumin values. However, when animals received colchicine simultaneously with CCl4, collagen synthesis and deposition were inhibited, and the liver function appeared normal. When a group of rats was made cirrhotic by chronic administration of CCl4, and then kept for 30 days without further treatment, fibrosis persisted and collagen synthesis was very low. However, the liver function was severely impaired. When similar rats received L-azetidine-2-carboxylic acid during the 30-days period following CCl4 administration, there was a slight but not significant improvement in liver function. The collagen synthesis and the extent of fibrosis were similar to the controls. However, if similar rats received colchicine during the 30 days period, collagen synthesis was almost negligible, there was a slight decrease in fibrosis and there was a great improvement in liver function. In all the cirrhotic animals studied, transferrin biosynthesis remained constant.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1115789     DOI: 10.1016/0005-2787(75)90186-0

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  11 in total

1.  Regional brain GABA metabolism and release during hepatic coma produced in rats chronically treated with carbon tetrachloride.

Authors:  M Díaz-Muñoz; R Tapia
Journal:  Neurochem Res       Date:  1988-01       Impact factor: 3.996

Review 2.  Current and future anti-fibrotic therapies for chronic liver disease.

Authors:  Don C Rockey
Journal:  Clin Liver Dis       Date:  2008-11       Impact factor: 6.126

3.  Collagen metabolism in the liver. An annotated and supplemented report of a workshop at the National Institutes of Health on February 28 and March 1, 1977.

Authors: 
Journal:  Am J Dig Dis       Date:  1978-07

Review 4.  Traditional management of liver disorders.

Authors:  M Messner; P Brissot
Journal:  Drugs       Date:  1990       Impact factor: 9.546

5.  Structural aspects of the liver in patients with biliary disease and portal hypertension.

Authors:  K Weinbren; N S Hadjis; L H Blumgart
Journal:  J Clin Pathol       Date:  1985-09       Impact factor: 3.411

6.  Effects of antifibrotic substances on pancreatic fibrosis following acute necrotizing pancreatitis.

Authors:  Y Kinami; N Sakata; M Takata
Journal:  Gastroenterol Jpn       Date:  1986-10

7.  In vitro correction of a deficiency of Con A-induced suppressor cell function in primary biliary cirrhosis by a pharmacological concentration of colchicine.

Authors:  D Ilfeld; E Theodor; G Delpre; O Kuperman
Journal:  Clin Exp Immunol       Date:  1984-08       Impact factor: 4.330

Review 8.  Hepatoprotective and Anti-fibrotic Agents: It's Time to Take the Next Step.

Authors:  Ralf Weiskirchen
Journal:  Front Pharmacol       Date:  2016-01-07       Impact factor: 5.810

9.  Carbon tetrachloride-induced hepatic fibrosis and cirrhosis in the developing rat: an experimental model of cirrhosis in childhood.

Authors:  P Trivedi; A P Mowat
Journal:  Br J Exp Pathol       Date:  1983-02

10.  To Investigate the Effect of Colchicine in Prevention of Adhesions Caused by Serosal Damage in Rats.

Authors:  İhsan Yıldız; Yavuz Savas Koca; Aziz Kemal Emek; Tekinalp Gelen
Journal:  Surg Res Pract       Date:  2015-09-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.